Your account is not claimed yet. You can sign up with ORCID to claim your account.

Lesley Mathews Griner (Lesley A Mathews Griner)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 2

Top Topics

High Throughput

Patient Reported Outcomes

Top Venues

Molecular cancer research : MCR

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Dandan Li, Anne M Miermont, Rushikesh Sable, Humair S Quadri, Lesley Mathews Griner, Scott E Martin, Taivan Odzorig, Soumita De, Marc Ferrer, Astin S Powers, Stephen M Hewitt, Rushikesh Sable
Scaffolding protein connector enhancer of kinase suppressor of Ras 1 (CNKSR1) regulates MAPK inhibition responsiveness in pancreas cancer via crosstalk with AKT signaling. Molecular cancer research : MCR (2023)
Kevin J Frankowski, Chen Wang, Samarjit Patnaik, Frank J Schoenen, Noel T Southall, Dandan Li, Yaroslav Teper, Wei Sun, Irawati Kandela, Deqing Hu, Christopher Dextras, Zachary Knotts, Yansong Bian, John Norton, Steve Titus, Marzena A Lewandowska, Yiping Wen, Katherine I Farley, Lesley Mathews Griner, Jamey Sultan, Zhaojing Meng, Ming Zhou, Tomas Vilimas, Astin S Powers, Serguei Kozlov, Kunio Nagashima, Humair S Quadri, Min Fang, Charles Long, Ojus Khanolkar, Warren Chen, Jinsol Kang, Helen Huang, Eric Chow, Esthermanya Goldberg, Coral Feldman, Romi Xi, Hye Rim Kim, Gary Sahagian, Susan J Baserga, Andrew Mazar, Marc Ferrer, Wei Zheng, Ali Shilatifard, Jeffrey Aube, Rushikesh Sable, Juan Jose Marugan, Sui Huang
Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis. Science translational medicine 10 (441) (2019)